These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9916880)

  • 1. Immune function alterations in mice tolerant to delta9-tetrahydrocannabinol: functional and biochemical parameters.
    Massi P; Sacerdote P; Ponti W; Fuzio D; Manfredi B; Viganó D; Rubino T; Bardotti M; Parolaro D
    J Neuroimmunol; 1998 Dec; 92(1-2):60-6. PubMed ID: 9916880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tramadol on immune responses and nociceptive thresholds in mice.
    Sacerdote P; Bianchi M; Manfredi B; Panerai AE
    Pain; 1997 Sep; 72(3):325-30. PubMed ID: 9313273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune function in mice tolerant to or abstinent from l-trans-delta 9-tetrahydrocannabinol.
    Bhargava HN; House RV; Thorat SN; Thomas PT
    Pharmacology; 1996 May; 52(5):271-82. PubMed ID: 8807671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of interleukin 2 activity by delta 9-tetrahydrocannabinol after stimulation with concanavalin A, phytohemagglutinin, or anti-CD3 antibody.
    Nakano Y; Pross SH; Friedman H
    Proc Soc Exp Biol Med; 1992 Nov; 201(2):165-8. PubMed ID: 1329110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential suppression of T-cell subpopulations by thc (delta-9-tetrahydrocannabinol).
    Pross SH; Klein TW; Newton CA; Smith J; Widen R; Friedman H
    Int J Immunopharmacol; 1990; 12(5):539-44. PubMed ID: 2170281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo.
    McKallip RJ; Lombard C; Martin BR; Nagarkatti M; Nagarkatti PS
    J Pharmacol Exp Ther; 2002 Aug; 302(2):451-65. PubMed ID: 12130702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta-9-tetrahydrocannabinol treatment results in a suppression of interleukin-2-induced cellular activities in human and murine lymphocytes.
    Trisler K; Specter S
    Int J Immunopharmacol; 1994 Jul; 16(7):593-603. PubMed ID: 7523319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response.
    McKallip RJ; Nagarkatti M; Nagarkatti PS
    J Immunol; 2005 Mar; 174(6):3281-9. PubMed ID: 15749859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of the immunosuppressive effect of delta9-tetrahydrocannabinol in streptozotocin-induced autoimmune diabetes.
    Li X; Kaminski NE; Fischer LJ
    Int Immunopharmacol; 2001 Apr; 1(4):699-712. PubMed ID: 11357882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
    Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of delta9-tetrahydrocannabinol on in vitro sensitization of mouse splenic lymphocytes.
    Lefkowitz SS; Klager K
    Immunol Commun; 1978; 7(5):557-66. PubMed ID: 359460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-level sarin-induced alteration of immune system reaction in inbred BALB/c mice.
    Kassa J; Krocová Z; Sevelová L; Sheshko V; Kasalová I; Neubauerová V
    Toxicology; 2003 May; 187(2-3):195-203. PubMed ID: 12699908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective modulation of immune function resulting from in vitro exposure to methylenedioxymethamphetamine (Ecstasy).
    House RV; Thomas PT; Bhargava HN
    Toxicology; 1995 Jan; 96(1):59-69. PubMed ID: 7863512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary conjugated linoleic acid influences the immune response of young and old C57BL/6NCrlBR mice.
    Hayek MG; Han SN; Wu D; Watkins BA; Meydani M; Dorsey JL; Smith DE; Meydani SN
    J Nutr; 1999 Jan; 129(1):32-8. PubMed ID: 9915872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic analysis of splenocyte subsets following acute morphine treatment in the rat.
    Fecho K; Lysle DT
    Cell Immunol; 1999 Aug; 195(2):137-46. PubMed ID: 10448013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differing effects of delta-9-tetrahydrocannabinol (THC) on murine spleen cell populations dependent upon stimulators.
    Pross SH; Nakano Y; Widen R; McHugh S; Newton CA; Klein TW; Friedman H
    Int J Immunopharmacol; 1992 Aug; 14(6):1019-27. PubMed ID: 1330945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential immunologic modulatory effects of tetrahydrocannabinol as a function of age.
    Ramarathinam L; Pross S; Plescia O; Newton C; Widen R; Friedman H
    Mech Ageing Dev; 1997 Jun; 96(1-3):117-26. PubMed ID: 9223115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of a lymphocyte membrane enzyme by delta9-tetrahydrocannabinol in vitro.
    Greenberg JH; Saunders ME; Mellors A
    Science; 1977 Jul; 197(4302):475-7. PubMed ID: 877571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of 9-ene-tetrahydrocannabinol on hormone release and immune function.
    Dax EM; Pilotte NS; Adler WH; Nagel JE; Lange WR
    J Steroid Biochem; 1989; 34(1-6):263-70. PubMed ID: 2560514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol.
    Lu H; Kaplan BL; Ngaotepprutaram T; Kaminski NE
    J Leukoc Biol; 2009 Feb; 85(2):322-9. PubMed ID: 18988696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.